藥物成份

共有 21387 個藥物成份

Caspofungin Acetate contains not less than 97.5 percent and not more than 102.0 percent of C52H88N10O15‧2C2H4O2 Calculated on the anhydrous, solvent-free basis.

• 關聯藥證數量: 1

Caspofungin Acetate contains not less than 98.0% and not more than 102.0% of C52H88N10O15.2(C2H4O2) calculated on anhydrous basis.

• 關聯藥證數量: 1

Caspofungin Acetate not less than 98.0% and not more than 102.0% of C52H88N10O15・2 C2H4O2, calculated on anhydrous basis.

• 關聯藥證數量: 1

Cassette ALP2S\nR1 Buffer/activators in vial A (liquid).\nR2=SR Substrate in vial C (liquid). \nActive Ingredients \n(1)2-Amino-2-methyl-1-propanol、\n(2)Magnesium acetate、\n(3)Zinc sulfate、\n(4)N-(2-hydroxyethyl)-ethylenediamine triacetic acid、\n(5)p-nitrophenyl phosphate

• 關聯藥證數量: 1

Cassette：0.025 mg Sodium citrate, 0.013 mg Gold chloride, 0.2μg anti-mouse β-HCG, 0.12μg anti-mouse IgG, 0.6μg Goat anti-mouse IgG, 0.6μg Goat anti-mouse α-HCG, 9 mg Sodium chloride, 0.278 mg Sodium phosphate, Monobasic crystal, 1.38 mg Sodium phosphate, Dibasic, Anhydrous, 2 mg NaN3, 0.02 g BSA.

• 關聯藥證數量: 1

Catalog #140100 provides enough reagents to perform 50-100 tests depending on the number of controls and titrations included per test run.

• 關聯藥證數量: 1

Catalog No. 06B229253 Simu1TRAC-SNB Dithiothreitol Solution.Catalog No. 06B257133 Simul TRAC-SNB Vitamin B12/Folate Tracer.Catalog No. 06B257150 Simu1TRAC-SNB Binder.Catalog No. 06B254975 Simu1TRAC-SNB Blank Reagen.Catalog No. 06B254851 Standard ACatalog No. 06B254860 Standard BCatalog No. 06B254878 Standard CCatalog No. 06B254886 Standard DCatalog No. 06B254916 Standard ECatalog No. 06B254924 Standard FCatalog No. 06B257176 Extracting Reagent.

• 關聯藥證數量: 1

Catalog No. 06B263676 T4 Monoclonal Antibody-Coated Tubes. Catalog No. 06B263666 T4 Serum Standard A-F. Catalog No. 06B263667 T4 Serum Standard A Catalog No. 06B263668 T4 Serum Standard B Catalog No. 06B263669 T4 Serum Standard C Catalog No. 06B263670 T4 Serum Standard D Catalog No. 06B263671 T4 Serum Standard E Catalog No. 06B263672 T4 Serum Standard F Catalog No. 06B263673 T4 Tracer.

• 關聯藥證數量: 1

Catalog# Description\n195-7112 Exchange Buffer.\n195-7113 Transfer Buffer.\n195-7115 Wash Reagent.\n195-7119HS Check Mix.\n195-7129 Internal Standard Diluent-Serum.\n195-7137 Internal Standard Diluent-Urine.\n195-7141 Mobile Phase Saturator Cartridge.\n195-7143 Extraction Cartridge.\n195-7144 Separation I Cartridge.\n195-7145 Separation II Cartridge.\n195-7150 Purification Cartridge.\n195-7518HS Internal Standard Combination.

• 關聯藥證數量: 1

Cefaclor contains not less than 96.0 percent and not more than 102.0 percent of C15H14ClN3O4S (anhydrous substance).

• 關聯藥證數量: 1

Cefaclor contains：96.0% to 102.0% of (C15H14ClN3O4), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefaclor has a potency of not less than 950 mcg and not more than 1020 mcg of C15H14ClN3O4S per mg calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefadroxil contains not less than 950 to 1050 mcg/mg of C16H17N3O5S‧H2O, calculated on anhydrous substance.

• 關聯藥證數量: 1

Cefadroxil has a potency equivalent to not less than 900mcg and not more than 1050mcg of C16H17N3O5S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefadroxil has a potency equivalent to not less than 950 ug and not more than 1050 ug of C16H17N3O5S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefalexin Monohydrate Content: 95.0 per cent to 102.0 per cent (anhydrous subtance)

• 關聯藥證數量: 1

Cefalexin contains not less than 95.0% and not more than 102.0% of C16H17N3O4S‧H2O, calculated on anhydrous substance.

• 關聯藥證數量: 1

Cefalexin(Cephalexin) contains not less than 950 μg and not more than 1030 μg of C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefalotin, Cefazolin, Cefuroxime, Cefotaxime, Ceftazidime, Ceftriaxone, Cefpodoxime, Cefepime, Cefotetan, Cefoxitin

• 關聯藥證數量: 1

Cefazolin Sodium Sterile has a potency equivalent to not less than 850μg and not more than 1050μg of cefazolin (C H N O S ) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefazolin Sodium contains not less than 95.0% and not more than 102.0% of C14H13N8NaO4S3 calculated on the anhydrous substance.

• 關聯藥證數量: 1

Cefazolin Sodium has a potency equivalent to not less than 95.0% and not more than 102.0% of C14H13NaN8O4S3, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefepime 0.016-256 μg/mL、Cefotaxime 0.016-256 μg/mL、Cefotaxime 0.002-32 μg/mL、Cefotetan 0.016-256 μg/mL、Ceftazidime 0.016-256 μg/mL、Ceftizoxime 0.016-256 μg/mL、Ceftriaxone 0.016-256 μg/mL、Ceftriaxone 0.002-32 μg/mL、Cefuroxime 0.016-256 μg/mL　變更處方為:空白．

• 關聯藥證數量: 1

Cefepime HCl contains the equivalent of not less than 825ug/mg and not more than 911ug/mg of Cefepime(C19H24N6O5S2), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefepime Hydrochloride and L-Arginine Sterile contain the equivalent of NLT 90.0% and NMT 115.0% of the labeled amount of cefepime (C19H24N6O5S2).

• 關聯藥證數量: 1

Cefepime Hydrochloride contains not less than 825ug and not more than 911ug of Cefepime (C19H24N6O5S2) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefiderocol Sulfate Tosylate

• 關聯藥證數量: 1

Cefinase discs impregnated with nitrocefin.

• 關聯藥證數量: 1

Cefixime Assay： anhydrous basis (ug/mg) Not less than 950 and not more than 1030

• 關聯藥證數量: 1

Cefixime the equivalent of 950~1030ug of (C16H15N5O7S2)per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefmetazole Sodium contains 860μg/mg~965μg/mg of C15H16N7NaO5S3 (on the anhydrous basis)

• 關聯藥證數量: 1

Cefmetazole Sodium contains not less than 860ug (potency) and not more than 965ug (potency) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefoperazone Sodium contains 87.0% to 101.5% of C25H26NaO8S2, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefoperazone Sodium\nNot less than 870ug and not more than 1015ug of Cefoperazone (C25H27N9O8S2) per mg (on the anhydrous basis.)

• 關聯藥證數量: 1

Cefotaxime Sodium contains not less than 96% and not more than the equivalent of 101% of C16H16N5NaO7S2,calculated on the dried basis.

• 關聯藥證數量: 1

Cefotaxime/cefotaxime + clavulanic acid：0.25-16/0.016-1 μg/mL\nCeftazidime/ceftazidime + clavulanic acid：0.5-32/0.064-4 μg/mL

• 關聯藥證數量: 1

Cefoxitin Sodium contains the equivalent of not less than 927ug and not more than 970ug of Cefoxitin (C16H17N3O7S2) per mg, corresponding to not less than 97.5% and not more than 102.0% of Cefoxitin Sodium (C16H16N3NaO7S2), calculated on the anhydrous and acetone- and methanol-free basis.

• 關聯藥證數量: 1

Cefoxitin Sodium contains the equivalent of not less than 927ug and not more than 970ug of cefoxitin(C16H17N3O7S2) per mg, corresponding to not less than 97.5% and not more than 102.0% of cefoxitin sodium (C16H16N3NaO7S2), calculated on the anhydrous and acetone and methanol free basis.

• 關聯藥證數量: 1

Cefoxitin Sodium contains the equivalent to not less than 927μg and not more than 970μg of cefoxitin (C16H17N3O7S2) per mg, corresponding to not less than 97.5% and not more than 102.0% ofcefoxitin sodium(C16H16N3NAO7S2), calculated on the anhydrous and acetone and methanol free basis.

• 關聯藥證數量: 1

Cefradine (Cephradine, enzymatic process) Content: sum of the percentage content of cefradine, cefalexin and 4',5'-dihydrocefradine: 96.0 % to 102.0% (anhydrous substance).

• 關聯藥證數量: 1

Cefradine contains of cefradine, cephalexin and 4´ ,5´ - dihydrocefradine: 96.0 per cent to 102.0 per cent (anhydrous substance).

• 關聯藥證數量: 1

Cefradine has a potency of not less than 900ug and not more than 1050ug of total Cephalosporins per mg, calculated as the sum of cefradine (C16H19N3O4S) and Cephalexin (C16H17N3O4S), calculated on anhydrous substance.

• 關聯藥證數量: 1

Cefradine(Cephradine) has a potency of not less than 900μg and not more than 1050μg of total cephalosporins per mg, calculated as the sum of cephradine(C16H19N3O4S) and cephalexin(C16H17N3O4S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftaroline fosamil

• 關聯藥證數量: 1

Ceftazidime Pentahydrate and Sodium Carbonate contains not less than 90.0% and not more than 105.0% of ceftazidime (C22H22N6O7S2) on the dried and sodium carbonate-free basis.

• 關聯藥證數量: 1

Ceftazidime contains not less than 95.0% and not more than 102.0% of Ceftazidime (C22H22N6O7S2), calculated on the dried basis.

• 關聯藥證數量: 1

Ceftizoxime Sodium (sterile) contains the equivalent of not less than 850 ug and not more than 995 ug of Ceftizoxime (C13H13N5O5S2) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftizoxime Sodium contains the equivalent of not less than 850 μg and not more than 995 μg of Ceftizoxime (C13H13N5O5S2)per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftolozane Sulfate

• 關聯藥證數量: 1

Ceftriaxone Sodium Sterile contains not less than 795 ug of ceftriaxone (C18H18N8O7S3) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftriaxone Sodium contains the equivalent of not less than 795 ug of ceftriaxone (C18H18N8O7S3) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftriaxone Sodium contains the equivalent of not less than 795ug of Ceftriaxone (C18H18N8O7S3)per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceftriaxone sodium contains the equivalent to not less than 795μg of ceftriaxone C18H18N8O7S3 per mg,calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefuroxime Axetil Amorphous contains not less than 745 ug/mg and not more than 875 ug/mg as Cefuroxime (C16H16N4O8S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefuroxime Axetil contains 96.0% to 102.0% of C20H22N4O10S per mg, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Cefuroxime Axetil contains the equivalent of not less than 745 ug and not more than 875 ug of cefuroxime (C16H16N4O8S) per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cefuroxime Sodium Content：96.0 per cent to 101.0 per cent (anhydrous substance)

• 關聯藥證數量: 1

Cefuroxime Sodium Sterile contains not less than 96.0% and not more than 102.0% of Cefuroxime Sodium (C16H15N4NaO8S), calculated on the anhydrous substance.

• 關聯藥證數量: 1

Cefuroxime Sodium contains the equivalent of not less than 855ug and not more than 1000ug of cefuroxime (C16H16N4O8S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Celecoxib Assay (Anhydrous substance)： 98.0-102.0%

• 關聯藥證數量: 1

Celecoxib contains 98.0 to 102.0% (anhydrous substance).

• 關聯藥證數量: 1

Celecoxib contains not less than 98.0% and not more than 102.0% of C17H14F3N3O2S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Celecoxib contains not less than 98.0% and not more than 102.0% of C17H14F3N3O2S, calculated on the dried basis.

• 關聯藥證數量: 1

Celecoxib contains not less than 98.00 percent and not more than 102.00 percent of Celecoxib, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Celecoxib contains not less than 98.5 percent and not more than 101.5 percent of Celecoxib (C17H14F3O2S), calculated on the dried.

• 關聯藥證數量: 1

Celecoxib contains not less than 98.5% and not more than 101.5% of Celecoxib (C17H14F3O2S), calculated on the dried basis.

• 關聯藥證數量: 1

Celite (14mg), Kaolin (14mg), Glass beads (50mg)

• 關聯藥證數量: 1

Centella Asiatica Triterpenes not less than 36.0% and not more than 44.0% of Asiaticoside calculated with reference to anhydrous substance.\nCentella Asiatica Triterpenes not less than 56.0% and not more than 64.0% of genins, as sum of Asiatic acid Madecassic acid calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Cephalexin has a potency of not less than 900mcg C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephalexin has a potency of not less than 950 mcg and not more than 1030 mcg of C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephalexin has a potency of not less than 950 ug and not more than 1030 ug of C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephalexin has a potency of not less than 950 ug and not more than 1030ug of C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephalexin has a potency of not less than 950μg and not more than 1030μg of C16H17N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephalinex, 20 x 3.0 ml

• 關聯藥證數量: 1

Cephazolin 30 ug/disc

• 關聯藥證數量: 1

Cephradine (Cefradine) has a potency of not less than 900 mcg and not more than 1050 mcg of total cephalosporins per mg, calculated as the sum of cephradine (C16H19N3O4S) and Cephalexin (C16H17N3O4S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephradine has a potency of not less than 900 ug and not more than 1050 ug of total cephalosporins per mg, calculated as the sum of cephradine (C16H19N3O4S) and Cephalexin (C16H17N3O4S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Cephradine has a potency of not less than 900 ug of C16H19N3O4S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Ceritinib

• 關聯藥證數量: 1

Cernitin T60 contains not less than 6.0% and not more than 8.0% of Amino Acids, calculated on the dried basis.

• 關聯藥證數量: 1

Certolizumab pegol

• 關聯藥證數量: 1

Cetirizine Dihydrochloride contain not less than 99.0% and not more than 100.5% of C21H27Cl3N2O3, calculated on dried basis.

• 關聯藥證數量: 1

Cetirizine Dihydrochloride contains not less than 99.0% and not more than 100.5%

• 關聯藥證數量: 1

Cetirizine Dihydrochloride contains not less than 99.0% and not more than 101.0% of C21H27Cl3N2O3, calculated on dried substance.

• 關聯藥證數量: 1

Cetirizine dihydrochloride contains not less than 99.0% and more than 100.5% of C21H27Cl3N2O3, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Cetrimide consists of trimethyltetradecylammonium bromide and may contain smaller amounts of dodecyl- and hexadecyl-trimethylammonium bromides.\nCetrimide contains not less than 96.0% and not more than 101.0% of alkyltrimethylammonium bromides, calculated as C17H38BrN (Mr336.4) on the dried substance.

• 關聯藥證數量: 1

Cetrimide contains 96.0 per cent to 101.0 per cent of alkyltrimethylammonium bromides, calculated as C17H38BrN(Mr 336.4)(dried substance).

• 關聯藥證數量: 1

Cetylpyridinium Chloride contains not less than 99.0% and not more than 102.0% of C21H38ClN, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Chemical UPROPV Vial 1 UPROPV Vial 2\nPolyethylene glycol stock solution (v/v) 90% 90%\nProclin 300 1.0 g/L 1.0 g/L\nNaCl crystalline 1.359 g/L 2.282 g/L\nKCl 0.708 g/L 3.504 g/L\nAmmonium chloride 0.0063 g/L 0.0063 g/L\n3-[N-morpholino]propanesulfonic acid buffer solution 10 mL/L 10 mL/L\nBovine albumin, BSA 0.160 g/L 0.640 g/L\nReverse osmosis water bring to volume bring to volume\n

• 關聯藥證數量: 1

Chemical Name Concentration\nCalibratorAmmonium iron (II) sulfateHydrochloric Acid Iron: 200μg/dl\n

• 關聯藥證數量: 1

Chemical components in sensor：Glucose dehydrogenase 5%、Electron shuttle 53%、Enzyme protector 4%、Non-reactive ingredients 38%\n泰博品管液成分為：D-glucose 0.03-0.30%、Inert ingredient 99.7%以上\n

• 關聯藥證數量: 1

Chemistry I Calibrator is a lyophilized multiconstituent bovine serum albumin base product containing calcium, creatinine, glucose, lactic acid, urea nitrogen and uric acid.

• 關聯藥證數量: 1

Chidamide 98.5%-101.0%

• 關聯藥證數量: 1

Chlamydia Direct IF (C+/C-)\nChlamydia Direct IF (ID)\nChlamydia Direct IF Prelevement

• 關聯藥證數量: 1

Chloramphenicol # 230729：5 mg, 1 cartridge # 230733：30 mg, 1 cartridge # 231274：30 mg, 1 0cartridges

• 關聯藥證數量: 1

Chloramphenicol 0.016-256 μg/mL。處方變更為：空白。

• 關聯藥證數量: 1

Chloramphenicol 30ug/disk

• 關聯藥證數量: 1

Chloramphenicol contains not less than 98.0% and not more than tje equivalent of 102.0 of C11H12Cl2N2O5, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Chlordiazepoxide (C16H14ClN3O) Content: 99.0 percent to 101.0 percent (dried substance)

• 關聯藥證數量: 1

Chlordiazepoxide Hydrochloride contains not less than 98.0% and not more than 102.0% of C16H14CLN3O, HCL calculated on the dried basis.

• 關聯藥證數量: 1